Log in with your email address username.


[Correspondence] Clinical disease activity in the CALM study – Authors’ reply

The Correspondence from Hans Herfarth and colleagues raised clinically relevant questions about our study1 of patients with Crohn’s disease, whose treatment was adjusted based on stringent criteria for clinical symptoms and biomarkers (tight control) or less stringent clinical criteria alone.